Kadimastem Market Cap

Kadimastem has a market cap or net worth of 109.20 million as of May 30, 2025. Its market cap has increased by 431.97% in one year.

Market Cap

109.20M

Enterprise Value

116.55M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

2,604.00

Market Cap Chart

Since June 13, 2013, Kadimastem's market cap has increased from 72.88M to 109.20M, an increase of 49.84%. That is a compound annual growth rate of 3.44%.

Market Cap History

Date	Market Cap	% Change
May 29, 2025	109.20M	103.12%
Dec 31, 2024	53.76M	116.19%
Dec 31, 2023	24.87M	-37.96%
Dec 29, 2022	40.08M	-66.07%
Dec 30, 2021	118.12M	197.88%
Dec 31, 2020	39.65M	-27.28%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	71.81B
Danel (Adir Yeoshua)	2.33B
Kamada	1.39B
Bait Bakfar	1.13B
SofWave Medical	735.98M
Novolog (Pharm-Up 1966)	725.40M
BrainsWay	722.10M
Ilex Medical	683.03M

Market Cap Rankings